Trans-Catheter Closure of Patent Ductus Arteriosus, which device should we use?

##plugins.themes.academic_pro.article.main##

Rym Gribaa
Sami Ouannes
Heithem Tangour
Sameh Ben Farhat
Houssem Thabet
Mehdi Slim
Aymen Elheraiche
Elyes Neffati

Abstract

Despite the operational experience in the percutaneous closure of Patent ductus arteriosus (PDA), complications can arise during the procedure. To overcome these complications the choice of the device must be adapted to each patient.
Aim : To report the experience of the cardiology department in the transcatheter device closure of PDA and to determine the influencing factors of choice of the device.
Methods : Our study included patients with patent ductus arteriosus that are admitted for transcatheter closure, between September 2003 and June 2016.
Result : One hundred and fifty-three patients were included in our study. Transcatheter closure was not done in 9 cases. The transcatheter closure was successful in 140 patients.
The complications were observed in 11 patients that includes device embolization in 3 cases, aortic protrusion in four cases pulmonary protrusion in three cases and inguinal hematoma in one another. Three predictive factors of complications were: age < 2 years, tubular PDA type C and ratio duct diameter/weight > 0.95.
A mild residual shunt was observed at the end of the procedure in 22.85 % of the patients. The risk of residual shunt was significantly increased when the age < 2 years, the large PDA, the presence of pulmonary hypertension and the tubular C PDA.
Conclusion :The choice of the device depends essentially on age, the weight and the duct anatomy.

Keywords:

patent ductus arteriosus, transcatheter closure, device

##plugins.themes.academic_pro.article.details##

References

  1. 1. Schneider DJ, Moore JS. Patent ductus arteriosus. Circulation 2006;114(17):1873-82. DOI: 10.1161/CIRCULATIONAHA.105.592063. 2. Porstmann W, Wierny L, Warnke H. Closure of persistent ductus arteriosus without thoracotomy. Ger Med Mon 1967;12(6):259-61 3. Liddy S, Oslizlok P, Walsh KP. Comparison of the results of transcatheter closure of patent ductus arteriosus with newer Amplatzer devices. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv 2013; 82(2):253 9. DOI: 10.1002/ccd.24768. Epub 2013 Feb 21. 4. Bruckheimer E, Godfrey M, Dagan T, Levinzon M, Amir G, Birk E. The Amplatzer Duct Occluder II Additional Sizes device for transcatheter PDA closure: initial experience. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv 2014;83 (7):1097 101. DOI: 10.1002/ccd.25445. Epub 2014 Mar 4. 5. Kumar SM, Subramanian V, Bijulal S, Krishnamoorthy KM, Sivasankaran S, Tharakan JA. Percutaneous closure of a moderate to large tubular or elongated patent ductus arteriosus in children younger than 3 years: is the ADO II appropriate? Pediatr Cardiol 2013; 34(7):1661 7. DOI: 10.1007/s00246-013-0700-x. Epub 2013 Apr 17. 6. Krichenko A , Benson LN , Burrows P, Möes CA , McLaughlin P, Freedom RM. Angiographic classification of the isolated persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol. 1989 ; 63(12) :877- 80. DOI: 10.1016/0002-9149(89)90064-7. 7. Rashkind WJ, Cuaso CC . Transcatheter closure of patent ductus arteriosus. Pediatric Cardiology 1979; 1: 3-7. DOI.org/10.1007/BF02307335 8. Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol. 2004; 44(3):513 9. DOI : 10.1016/j.jacc.2004.03.074. 9. Cho EH, Song J, Kang I-S, Huh J, Lee SY, Choi EY, et al. Transcatheter closure of small ductus arteriosus with amplatzer vascular plug. Korean J Pediatr 2013; 56(9):396 400. DOI: 10.3345/kjp.2013.56.9.396. Epub 2013 Sep 10. Bilkis AA, Alwi M, Hasri S, Haifa AL, Geetha K, Rehman MA, et al. The Amplatzer duct occluder: experience in 209 patients. J Am Coll Cardiol 2001;37(1):258 61. DOI: 10.1016/s0735-1097(00)01094-9. 11. Saliba Z, El-rassi I, Helou D, Abou-Jaoudeh P, Chehab G, Daou L, et al. Development of catheter-based treatment of patent ductus arteriosus: a medium-sized centre experience. Arch Cardiovasc Dis 2009;102(2):111 8. DOI: 10.1016/j.acvd.2008.11.001. Epub 2009 Jan 24. 12. Forbes TJ, Harahsheh A, Rodriguez-Cruz E, Morrow WR, Thomas R, Turner D, et al. Angiographic and hemodynamic predictors for successful outcome of transcatheter occlusion of patent ductus arteriosus in infants less than 8 kilograms. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv 2004 ; 61(1):117-22. DOI: 10.1002/ccd.10751. 13. Ghasemi A, Pandya S, Reddy SV, Turner DR, Du W, Navabi MA, et al. Trans-catheter closure of patent ductus arteriosus-What is the best device? Catheter Cardiovasc Interv 2010 ;76(5):687-95. DOI: 10.1002/ccd.22393. 14. Backes CH, Rivera BK, Bridge JA, Armstrong AK, Boe BA, Berman DP et al. Percutaneous Patent Ductus Arteriosus (PDA) Closure During Infancy: A Meta-analysis. Pediatrics 2017; 139 (2): e20162927. DOI: 10.1542/peds.2016-2927. Epub 2017 Jan 13. 15. Santiago Peña JJ, Acuña M , Das Neves B , Sanchez S, Camacho NI , Gonzalez N .Percutaneous Closure of Window-Type Patent Ductus Arteriosus With the AMPLATZER TM Septal Occluder. Revista Brasileira de Cardiologia Invasiva 2014; 22 : 99-101. DOI.org/10.1590/0104-1843000000016 16. Sungur M, Karakurt C, Ozbarlas N, Baspinar O. Closure of patent ductus arteriosus in children, small infants, and premature babies with Amplatzer duct occluder II additional sizes: multicenter study. Catheter Cardiovasc Interv off J Soc Card Angiogr Interv 2013; 82(2):245 52. DOI : 10.1002/ccd.24905. Epub 2013 Apr 8. 17. Gross AAR, Donnelly JP. Closure of tubular patent ductus arteriosus in infants with the Amplatzer Vascular Plug II. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv 2013; 81(7):1188 93. DOI: 10.1002/ccd.24754. Epub 2013 Feb 12.